Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-21 5:54 pm Unchanged |
2024-09-30 | 13G | Kezar Life Sciences, Inc. KZR |
Barclays PLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-03-06 5:46 pm Purchase |
2025-02-28 | 13G | Kezar Life Sciences, Inc. KZR |
BML Investment Partners, L.P. | 368,594 5.100% |
368,594 (New Position) |
Filing History |
| 2025-03-03 4:01 pm Purchase |
2025-02-28 | 13D | Kezar Life Sciences, Inc. KZR |
Equal Talent Investments Limited | 616,502 8.660% |
616,502 (New Position) |
Filing History |
| 2025-02-14 10:42 am Purchase |
2024-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
Avidity Partners Management LP | 502,600 6.900% |
55 (+0.01%) |
Filing History |
| 2025-01-16 6:33 pm Sale |
2024-12-03 | 13D | Kezar Life Sciences, Inc. KZR |
Morningside Venture Investments Limited | 616,502 8.450% |
-8,953 (-1.43%) |
Filing History |
| 2024-11-14 12:24 pm Sale |
2024-09-30 | 13G | Kezar Life Sciences, Inc. KZR |
Barclays PLC | 0 0.000% |
-382,878 (Position Closed) |
Filing History |
| 2024-10-08 4:20 pm Purchase |
2024-10-01 | 13D | Kezar Life Sciences, Inc. KZR |
TANG CAPITAL MANAGEMENT LLC | 720,000 9.900% |
720,000 (New Position) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Kezar Life Sciences, Inc. KZR |
BLACKROCK INC BLK |
83,037 1.100% |
-398,690 (-82.76%) |
Filing History |
| 2024-02-14 6:47 pm Sale |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
ORBIMED ADVISORS LLC | 192,700 2.700% |
-156,812 (-44.87%) |
Filing History |
| 2024-02-14 6:44 pm Purchase |
2024-02-13 | 13G | Kezar Life Sciences, Inc. KZR |
Barclays PLC | 382,878 5.270% |
382,878 (New Position) |
Filing History |
| 2024-02-14 06:50 am Sale |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
Avidity Partners Management LP | 502,545 6.900% |
-175,695 (-25.90%) |
Filing History |
| 2024-02-13 11:55 am Purchase |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
SUVRETTA CAPITAL MANAGEMENT, LLC | 716,759 9.900% |
366,333 (+104.54%) |
Filing History |
| 2024-02-13 09:50 am Sale |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
Prosight Management LP | 336,533 4.600% |
-70,790 (-17.38%) |
Filing History |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BLACKROCK INC BLK |
481,727 6.600% |
58,635 (+13.86%) |
Filing History |
| 2024-01-23 09:15 am Sale |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
STATE STREET CORP STT |
111,605 1.540% |
-313,791 (-73.76%) |
Filing History |
| 2024-01-22 4:04 pm Sale |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
MILLENNIUM MANAGEMENT LLC | 292,756 4.000% |
-85,297 (-22.56%) |
Filing History |
| 2023-08-17 5:14 pm Unchanged |
2023-08-15 | 13D | Kezar Life Sciences, Inc. KZR |
Morningside Venture Investments Limited | 625,455 8.600% |
0 (Unchanged) |
Filing History |
| 2023-06-21 4:02 pm Purchase |
2023-06-16 | 13G | Kezar Life Sciences, Inc. KZR |
MILLENNIUM MANAGEMENT LLC | 378,053 5.200% |
88,404 (+30.52%) |
Filing History |
| 2023-04-20 6:20 pm Purchase |
2023-04-11 | 13G | Kezar Life Sciences, Inc. KZR |
Prosight Management LP | 407,323 5.800% |
407,323 (New Position) |
Filing History |
| 2023-02-14 4:32 pm Purchase |
2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
ORBIMED ADVISORS LLC | 349,512 5.100% |
349,512 (New Position) |
Filing History |